School of Medicine

Wayne State University School of Medicine

Vaccinex - Study comparing the safety and tolerability of VX 15/2503 in patient with Multiple Sclerosis - Closed to Enrollment

This is a 12 week study evaluating the safety and tolerability of VX15/2503 in patients with multiple sclerosis. Patients will be randomly assigned either one dose of VX15/2503 (IV Infusion) or one dose of Placebo (IV Infusion).

 

Eligibility: Patients 18-60 years old diagnosed with Multiple Sclerosis for at least 1 year, who are able to walk at least 20 meters without resting.

 

For more information visit: Vaccinex